These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34260956)

  • 1. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!
    Núñez-Zapata SF; Benites-Peralta B; Mayta-Tristan P; Rodríguez-Morales AJ
    Int J Infect Dis; 2021 Aug; 109():244-246. PubMed ID: 34260956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
    Haq M; Rehman A; Ahmad J; Zafar U; Ahmed S; Khan MA; Naveed A; Rajab H; Muhammad F; Naushad W; Aman M; Rehman HU; Ahmad S; Anwar S; Haq NU
    Infection; 2021 Oct; 49(5):983-988. PubMed ID: 34032997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
    Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
    BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão.
    Silva AAMD; Lima-Neto LG; Azevedo CMPES; Costa LMMD; Bragança MLBM; Barros Filho AKD; Wittlin BB; Souza BF; Oliveira BLCA; Carvalho CA; Thomaz EBAF; Simões-Neto EA; Leite Júnior JF; Cosme LMSS; Campos MAG; Queiroz RCS; Costa SS; Carvalho VA; Simões VMF; Alves MTSSBE; Santos AMD
    Rev Saude Publica; 2020; 54():131. PubMed ID: 33331525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue and COVID-19 Co-Circulation in the Peruvian Amazon: A Population-Based Study.
    Pons MJ; Mayanga-Herrera A; Ulloa GM; Ymaña B; Medina S; Alava F; Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Rodríguez-Ferrucci H; Morrison AC; Quispe AM
    Am J Trop Med Hyg; 2023 Jun; 108(6):1249-1255. PubMed ID: 37094790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil.
    de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Grespan R; de Souza Siqueira Quintans J; Dos Santos DM; da Silva DN; de Oliveira YLM; de Franca MNF; da Conceição Silva M; de Sá DLF; de Carvalho FO; de Souza MF; de Oliveira Góes MA; Santos VS; Martins-Filho PR
    Pathog Glob Health; 2023 Jul; 117(5):505-512. PubMed ID: 36094065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.
    Zaidi S; Rizwan F; Riaz Q; Siddiqui A; Khawaja S; Imam M; Naz A; Waheed S; Shamsi T
    J Public Health (Oxf); 2021 Apr; 43(1):3-8. PubMed ID: 32940328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High seroprevalence of SARS_COV-2 in Bergamo: evidence for herd immunity or reason to be cautious?
    Signorelli C; Zucchi A; Tersalvi CA; Ciampichini R; Beato E; Balzarini F; Odone A; Middleton J
    Int J Public Health; 2020 Dec; 65(9):1815-1817. PubMed ID: 33216153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic].
    Popova AY; Smirnov VS; Ezhlova EB; Mel'nikova AA; Samoilova LV; Lyalina LV; Semenova EV; Gurskiy MA; Aksenova EA; Arbuzova TV; Totolian AA
    Vopr Virusol; 2021 Sep; 66(4):299-309. PubMed ID: 34545722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 herd immunity of the Kyrgyz population in 2021.
    Popova AY; Kasymov OT; Smolenski VY; Smirnov VS; Egorova SA; Nurmatov ZS; Milichkina AM; Suranbaeva GS; Kuchuk TE; Khamitova IV; Zueva EV; Ivanov VA; Nuridinova ZN; Derkenbaeva AA; Drobyshevskaya VG; Sattarova GZ; Kaliev MT; Gubanova AV; Zhimbaeva OB; Razumovskaya AP; Verbov VN; Likhachev IV; Krasnov AV; Totolian AA
    Med Microbiol Immunol; 2022 Aug; 211(4):195-210. PubMed ID: 35780233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.
    Nah EH; Cho S; Park H; Hwang I; Cho HI
    BMJ Open; 2021 Apr; 11(4):e049837. PubMed ID: 33895722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia.
    Alhazmi A; Alamer E; Abdelwahab S; Khamjan N; Hamami A; Haddad M; Darraj M; Hashem AM; Algaissi A
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.
    Chisale MRO; Ramazanu S; Mwale SE; Kumwenda P; Chipeta M; Kaminga AC; Nkhata O; Nyambalo B; Chavura E; Mbakaya BC
    Rev Med Virol; 2022 Mar; 32(2):e2271. PubMed ID: 34228851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2.
    Fiore JR; Centra M; De Carlo A; Granato T; Rosa A; Sarno M; De Feo L; Di Stefano M; Errico M; Caputo SL; De Nittis R; Arena F; Corso G; Margaglione M; Santantonio TA
    J Med Virol; 2021 Mar; 93(3):1739-1742. PubMed ID: 32790086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study.
    Struck NS; Lorenz E; Deschermeier C; Eibach D; Kettenbeil J; Loag W; Brieger SA; Ginsbach AM; Obirikorang C; Maiga-Ascofare O; Sarkodie YA; Boham EEA; Adu EA; Asare G; Amoako-Adusei A; Yawson A; Boakye AO; Deke J; Almoustapha NS; Adu-Amoah L; Duah IK; Ouedraogo TA; Boudo V; Rushton B; Ehmen C; Fusco D; Gunga L; Benke D; Höppner Y; Rasolojaona ZT; Rasamoelina T; Rakotoarivelo RA; Rakotozandrindrainy R; Coulibaly B; Sié A; Awuah AA; Amuasi JH; Souares A; May J
    BMC Public Health; 2022 Sep; 22(1):1676. PubMed ID: 36064368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.